MDPLF
Medicus Pharma Ltd., a biotech/life sciences company, focuses on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. It is developing SkinJect with an indication for basal cell carcinoma. The company is headquartered in Toronto, Canada.
MDPLF (MDPLF) - Total Assets
Latest total assets as of June 2024: $8.78 Million USD
Based on the latest financial reports, MDPLF (MDPLF) holds total assets worth $8.78 Million USD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MDPLF - Total Assets Trend (2021–2023)
This chart illustrates how MDPLF’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MDPLF - Asset Composition Analysis
Current Asset Composition (December 2023)
MDPLF's total assets of $8.78 Million consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 90.8% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2023)
This chart illustrates how MDPLF's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MDPLF's current assets represent 100.0% of total assets in 2023, unchanged from 100.0% in 2021.
- Cash Position: Cash and equivalents constituted 90.8% of total assets in 2023, down from 100.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
MDPLF Competitors by Total Assets
Key competitors of MDPLF based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
China | CN¥3.03 Billion |
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
China | CN¥877.99 Million |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥2.58 Billion |
|
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367
|
China | CN¥1.52 Billion |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
|
China | CN¥13.11 Billion |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198
|
China | CN¥774.73 Million |
|
PharmGen Science Inc
KO:004720
|
Korea | ₩331.46 Billion |
MDPLF - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - MDPLF generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - MDPLF is currently not profitable relative to its asset base.
MDPLF - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.11 | 0.01 | 0.01 |
| Quick Ratio | 4.11 | 0.01 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $6.41 Million | $ -13.17 Million | $ -13.17 Million |
MDPLF - Advanced Valuation Insights
This section examines the relationship between MDPLF's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.12 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 569.7% |
| Total Assets | $1.89 Million |
| Market Capitalization | $25.91K USD |
Valuation Analysis
Below Book Valuation: The market values MDPLF's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: MDPLF's assets grew by 569.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for MDPLF (2021–2023)
The table below shows the annual total assets of MDPLF from 2021 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $1.89 Million | +569.75% |
| 2022-12-31 | $282.65K | +260.00% |
| 2021-12-31 | $78.51K | -- |